Found 6 matching trials
An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB). PHASE3 This study is designed to evaluate the safety, tolerability, and efficacy o...
Show More Location
Coastal Clinical Research Inc.
Learn More & Join Trial
A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) PHASE3 This study is designed to evaluate the safety, tolerability, and efficacy o...
Show More Location
Central Alabama Research
Learn More & Join Trial
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) PHASE3 This study will assess the efficacy of vibegron compared with placebo in me...
Show More Location
Urology Centers of Alabama
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome PHASE2 This study will evaluate the efficacy and safety of vibegron, a beta-3 adre...
Show More Location
Synexus Clinical Research US, Inc.-Simon Williamson Clinic
Learn More & Join Trial
A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004) PHASE1 The study is designed to investigate the effects of the investigational dru...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) PHASE2 This is a 2-part study to assess if vibegron (MK-4618) reduces the number o...
Show More Location
Multiple Locations
Learn More & Join Trial